Controlled Epstein-Barr virus reactivation after allogeneic transplantation is associated with improved survival-Reference-Cited by-同舟云学术

Controlled Epstein-Barr virus reactivation after allogeneic transplantation is associated with improved survival

Published:2014-02-15 Issue:5 Volume:92 Page:421-428
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Auger Sophie¹,Orsini Mattea²,Céballos Patrice¹,Fegueux Nathalie¹,Kanouni Tarik¹,Caumes Bastien³,Klein Bernard⁴⁵,Villalba Martin⁴,Rossi Jean-François¹⁴⁵

Affiliation:

1. Unit for Allogeneic Transplantation; Department of Hematology; CHU de Montpellier; Montpellier France

2. Unit INSERM 2415; University Biostatistical and Epidemiology Institute; Montpellier France

3. Direction de la Recherche Clinique; CHU de Nîmes; Nîmes France

4. INSERM U1040; Institut de Recherche en Biothérapie; Hôpital St Eloi; Montpellier France

5. Université Montpellier I; Montpellier France

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12260/fullpdf

Reference31 articles.

1. The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal;Chang;Virus Res,2009

2. Cellular responses to viral infection in humans: lessons from Epstein-Barr virus;Hislop;Annu Rev Immunol,2007

3. Epstein-Barr virus post-transplant lymphoproliferative disorders: pathogenetic insights for targeted therapy;Nourse;Am J Transplant,2011

4. Immune surveillance and therapy of lymphomas driven by Epstein-Barr virus protein LMP1 in a mouse model;Zhang;Cell,2012

5. Stem cell transplantation with reduced-intensity conditioning regimens: a review of ten years experience with new transplant concepts and new therapeutic agents;Barrett;Leukemia,2006

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanistic Understanding of EBV+Lymphoproliferative Disease Development After Transplantation;Transplantation;2024-02-05

2. Features of Epstein–Barr Virus and Cytomegalovirus Reactivation in Acute Leukemia Patients After Haplo-HCT With Myeloablative ATG-Containing Conditioning Regimen;Frontiers in Cellular and Infection Microbiology;2022-05-16

3. Association Between Cytomegalovirus and Epstein-Barr Virus Co-Reactivation and Hematopoietic Stem Cell Transplantation;Frontiers in Cellular and Infection Microbiology;2022-03-25

4. Epstein–Barr virus and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation in patients with non–Hodgkin lymphoma: the prevalence and impacts on outcomes;Annals of Hematology;2021-09-04

5. Incidence and impact of Epstein-Barr virus events in the early phase after allogeneic hematopoietic cell transplantation;Annals of Hematology;2021-06-03